scholarly journals CpG Oligodeoxynucleotides Attenuate OVA-Induced Allergic Airway Inflammation via Suppressing JNK-Mediated Endoplasmic Reticulum Stress

2021 ◽  
Vol Volume 14 ◽  
pp. 1399-1410
Author(s):  
Hai-Yun Zhang ◽  
Qiu-Meng Xie ◽  
Cui-Cui Zhao ◽  
Jia-Feng Sha ◽  
Ya Ruan ◽  
...  
2019 ◽  
Vol 39 (11) ◽  
Author(s):  
Chang-Ming Lv ◽  
Hui-Mei Wu ◽  
Ling Wu ◽  
Guang-Hong Xu ◽  
Zhi-Lai Yang ◽  
...  

Abstract Sevoflurane was found to show protective roles in mice with asthma, however, the mechanism of which needs further exploring. Aquaporins (AQPs) have been demonstrated to be involved in the pathogenesis of asthma, while endoplasmic reticulum stress has been reported to be related to many inflammatory diseases and involved in protein processing, including AQPs. The present study aimed to determine the role of sevoflurane in AQPs (AQP1,3,4,5) expression in mice with allergic airway inflammation and the probable mechanism. The increased number of inflammatory cells infiltrating the lung tissue, and the elevated levels of tumor necrosis factor-α (TNF-α) and interleukin (IL) 13 (IL-13) were all decreased after sevoflurane treatment (all P<0.05). Meanwhile, mRNA levels of AQP1 and AQP5 but not AQP3 and AQP4 were decreased in ovalbumin (OVA)-induced allergic mice lung. Both the decreased mRNA expression and protein levels of AQP1 and AQP5 in allergic lung tissues were reversed by sevoflurane treatment. Furthermore, we established that sevoflurane inhibited the OVA-induced protein increase in the endoplasmic reticulum (ER) stress markers BiP and C/EBP homologous protein (CHOP). Collectively, these findings suggested that sevoflurane modulated the expression and protein level of AOPs (AQP1, AQP5) as well as inhibited ER stress response in OVA-induced allergic airway inflammation of mice.


Life Sciences ◽  
2019 ◽  
Vol 239 ◽  
pp. 117067 ◽  
Author(s):  
Hui-Mei Wu ◽  
Qiu-Meng Xie ◽  
Cui-Cui Zhao ◽  
Juan Xu ◽  
Xiao-Yun Fan ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Takuma Okajima ◽  
Suguru Shigemori ◽  
Fu Namai ◽  
Tasuku Ogita ◽  
Takashi Sato ◽  
...  

CpG-oligodeoxynucleotides (CpG-ODNs) constitute an attractive alternative for asthma treatment. However, very little evidence is available from studies on the oral administration of CpG-ODNs in animals. Previously, we developed acid-resistant particles (named ODNcap) as an oral delivery device for ODNs. Here, we showed that free feeding of an ODNcap-containing feed prophylactically attenuates allergic airway inflammation, hyperresponsiveness, and goblet cell hyperplasia in an ovalbumin-induced asthma model. Using transcriptomics-driven approaches, we demonstrated that injury of pulmonary vein cardiomyocytes accompanies allergen inhalation challenge, but is inhibited by ODNcap feeding. We also showed the participation of an airway antimicrobial peptide (Reg3γ) and fecal microbiota in the ODNcap-mediated effects. Collectively, our findings suggest that daily oral ingestion of ODNcap may provide preventive effects on allergic bronchopulmonary insults via regulation of mechanisms involved in the gut-lung connection.


2015 ◽  
Vol 21 ◽  
pp. 85-86
Author(s):  
William Kurban ◽  
Salma Makhoul Ahwach ◽  
Melanie Thomas ◽  
Luisa Onsteed-Haas ◽  
Michael Haas

Sign in / Sign up

Export Citation Format

Share Document